Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-02-22
2011-02-22
Ford, Allison M (Department: 1651)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S141100, C424S142100, C424S144100, C424S152100
Reexamination Certificate
active
07892551
ABSTRACT:
The invention provides a method of enumerating the number of cells of a cell type in a cell sample by (a) counting the white blood cells in the cell sample to obtain the white blood cell population of the sample; (b) determining the proportion or percentage of the cells of the cell type in the white blood cell population in the sample; and (c) calculating the number of cells of the cell type in the sample. The cell type may be a lymphocyte sub-set selected from the group comprising CD4+ lymphocytes, CD 45 cells, CD19 cells, CD16 and CD56 positive cells, CD8 cells, CD3 cells or any combination thereof. The method is particularly useful in monitoring the immune status of a patient infected with HIV or other immune deficiency state or disease or condition where CD4+ lymphocytes or CD4+ T cells are monitored or counted. The invention also provides a kit comprising antibodies necessary for carrying out said cell enumeration.
REFERENCES:
patent: 3896307 (1975-07-01), Trowe
patent: 5064616 (1991-11-01), Brosnan et al.
patent: 5385822 (1995-01-01), Melnicoff et al.
patent: 5776709 (1998-07-01), Jackson et al.
patent: 5812419 (1998-09-01), Chupp et al.
patent: 5945293 (1999-08-01), Siiman et al.
patent: 6010902 (2000-01-01), Ledbetter et al.
patent: 2003/0018438 (2003-01-01), Nestor, Jr. et al.
patent: 0470810 (1992-02-01), None
Ian Storie et al., “Flow Rate Calibration II: A Clinical Evaluation Study Using PanLeucoGating as a Single-Platform Protocol”, Clinical Cytometry, 55B:8-13 (2003).
D.K. Glencross et al., “Results from the WHO/NHLS/QASI CD4 Regional External Quality Assessment Scheme (REQAS): Multi-Site Evaluation of CD4 Technology Performance”, 2ndSouth African AIDS Meeting, Jun. 2005.
W. Stevens et al., “Affordable HIV Diagnosis and Monitoring for Scaling Up ARV Treatment Programmes”, The Southern African Journal of HIV Medicine, Sep. 2005, pp. 38-41.
L. Scott et al., “Monitoring Reproducibility of Single Analysis, Single Platform CD4 Cell Counts in a High Volume, Low Resource Laboratory Setting Using Sequential Bead Count Rates”, Clinical Cytometry, 67B:31-32 (2005).
T. Rehle et al., “HIV-positive educators in South African public schools”, Education Labour Relations Council, 2005.
T. Rehle et al., “Appendix and Addenda—HIV-positive educators in South African public schools”, Education Labour Relations Council, 2005.
NCCLS, “Clinical Applications of Flow Cytometry: Quality Assurance and Immunophenotyping of Lymphocytes; Approved Guideline”, 1998, Abstract, vol. 18, No. 21, pp. H-42 A.
U.S. Food and Drug Administration, “Recognized Consensus Standards”, www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfstandards/detail.CFM?Standard—identification—NO-10448, Mar. 30, 2006.
G. Vercauteren et al., “Impact of Who External Quality Assessment (EQA) programme on the laboratory performance of CD4 enumeration for monitoring of ARV therapy in Resource Limited settings”, World Health Organization, Conference: AIDS2006 (Abstract), (2006).
D. Glencross et al., “Improved between-laboratory performance of South African NHLS laboratories using PLG CD4 methodology for the national antiretroviral (ARV) treatment programme”, University of the Witwatersrand, Aug. 14, 2006 (Abstract).
D. Glencross et al., “CD45-Assisted PanLeucogating for Accurate, Cost-Effecive Dual-Platform CD4+ T-Cell Enumeration”, Cytometry (Clinical Cytometry) 50: 69-77 (2002).
M. Willja et al., “Less Expensive CD4+ T Cell Monitorying Using Panleucogating”, AIDS 2002 Barcelona, Jul. 7-12, 2002 (Abstract).
K. Pattanapanyasat et al., “A Multicenter Evaluation of the PanLeucogating Method and the Use of Generic Monoclonal Antibody Reagents for CD4 Enumeration in HIV-Infected Patients in Thailand”, Cytometry Part B (Clinical Cytometry) 65B: 29-36 (2005).
K. Pattanapanyasat et al., “Low-Cost CD4 Enumeration in HIV-Infected Patients in Thailand”, Asian Pacific Journal of Allergy and Immunology, 21: 105-113 (2003).
T. Denny et al., “Determination of CD4 and CD8 Lymphocyte Subsets by a New Alternative Fluorescence Immunoassay”, Clinical and Diagnostic Laboratory Immunology, May 1995, p. 330-336.
L. Scott et al., “Antiviral Therapy 8 (suppl 1) Abstract No. 1226”, 2ndInternational AIDS Conference on HIV Pathogenesis and Treatment, France, 2003.
T. Denny et al., “A Multi-Lab Study of CD4 Counts Using Flow Cytometric PanLeukoGating (PLG): A Niaid-Daids Immunology Quality Assessment Program Study”, 13thConference Retrovirology and Opportunistic Infection (CROI), Boston, Feb. 2006.
N. Sippy et al., “Comparison of the Panleucogating technique with four-color heterogenous gating for CD4+ T cell enumeration by flowcytometry in HIV-1 infected individuals in Barbados”, Ladymeade Reference Unit, Ministry of Health, Barbados, No Date.
Centers for Disease Control (USA), “1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV)”, Morbidity and Mortality Weekly Report, vol. 46, No. RR-2, pp. I-II, 1-29, (1997).
Brando et al., “Cytofluorometric Methods for Assessing Absolute Numbers of Cell Subsets in Blood”, Cytometry, 2000, vol. 42, pp. 327-346.
Nicholson et al., “Use of CD45 Fluorescence and Side-Scatter Characteristics for Gating Lymphocytes When Using the Whole Blood Lysis Procedure of Flow Cytometry”, Cytometry, 1995, vol. 26, No. 1, pp. 16-21.
Schnizlein-Bick et al., “Evaluation of TruCount Absolute-Count Tubes for Determining CD4 and CD8 Cell Nos. in Human Immunodeficiency Virus-Positive Adults”, Clinical and Diagnostic Laboratory Immunology, May 2000, vol. 7, No. 3, pp. 336-343.
Loken et al., “Establishing Optimal Lymphocyte Gates for Immunophenotyping by Flow Cytometry”, 1990, vol. 11, pp. 453-459.
Barnett et al., “Absolute CD4+ T-Lymphocyte and CD34+ Stem Cell Counts by Single-Platform Flow Cytometry: The Way Forward”, British Journal of Haematology, 1999, vol. 106, No. 4, pp. 1059-1062.
Sherman et al., “CD4T Cell Enumeration in HIV Infection with Limited Resources”, Journal of Immunological Methods, 1999, vol. 222, No. 1-2, pp. 209-217.
Center et al., “The Lymphocyte Chemoattractant Factor”, J. Lab Clin Med, 1995, vol. 125, No. 2, pp. 167-172.
Stewart et al., “Human T Lymphocytes and Monocytes Bear the Same LEU-3(T4) Antigen”, Journal of Immunology, 1986, vol. 136, No. 10, pp. 3773-3778.
Dorland's Medical Dictionary, “Count- Counter” hhtp://merckmedicus.com/pplus/hcp/thcp—dorlands-content.jsp:48 pg=/ppdocs/us/common/dorlands/dorland/dmd-c-062.htm#961741 accessed Jun. 16, 2005.
Buchanan & Ingersoll & Rooney PC
Ford Allison M
National Health Laboratory Service
LandOfFree
Antibody kit for enumeration of CD4+ lymphocytes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody kit for enumeration of CD4+ lymphocytes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody kit for enumeration of CD4+ lymphocytes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2648175